www.fgks.org   »   [go: up one dir, main page]

Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus

Clin Liver Dis. 2004 May;8(2):445-60, viii. doi: 10.1016/j.cld.2004.02.005.

Abstract

Hepatitis B virus (HBV) shares routes of transmission, namely exchange of infected body fluids, sharing of contaminated needles, and blood transfusion, with other hepatotropic viruses, such as hepatitis C virus (HCV) and hepatitis D virus (HDV) and with systemic retroviral infections, such as the human immunodeficiency virus (HIV). Thus, many HBV infected patients are co-infected with other viral pathogens. Co-infection appears to increase the risk of progression of liver disease and may have important ramifications on choice of antiviral medication and treatment regimen. This article reviews the current knowledge of co-infection of HBV with HCV, HDV, and HIV.

Publication types

  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / standards
  • Antiviral Agents / therapeutic use
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV*
  • Hepacivirus*
  • Hepatitis B / drug therapy
  • Hepatitis B / virology*
  • Hepatitis B virus*
  • Hepatitis C / drug therapy
  • Hepatitis C / virology*
  • Hepatitis D / drug therapy
  • Hepatitis D / virology*
  • Hepatitis Delta Virus*
  • Humans
  • Interferon-alpha / therapeutic use

Substances

  • Antiviral Agents
  • Interferon-alpha